To provide project management services to include management of design and performance by CDC of an animal research study involving application of microarray patches (MAPs) containing antiretrovirals for HIV treatment to rhesus macaques.
To optimize interventions and tools to enable the elimination and eradication of prioritized Neglected Tropical Diseases (NTDs) as identified by the London Declaration.
To enable veterinary students from across the United States, Canada and the Caribbean to learn more about opportunities in public health for veterinary professionals.
To conduct an evaluation before and two years after the introduction of the Pneumococcal conjugate vaccine (PCV) to study the direct and indirect impact of PCV introduction on vaccine-type pneumococcal carriage among healthy Indonesian children under five years of age.
To support key initiatives addressing typhoid and cholera including the evaluation of the Burden and Risk Assessment in Typhoid tool, the assessment for identifying and reaching under-immunized children in Ethiopia and as-needed technical assistance on targeted activities in the Eastern Mediterranean Region.
To assess the impact of the Pneumococcal conjugate vaccine catch up campaign among internally displaced populations in the northern Sahel region of Burkina Faso. This effort will implement and evaluate the impact of changing the pneumococcal conjugate vaccine schedule.
To assist the Ministry of Public Health (MOPH) in establishing a Field Epidemiology Training Program (FETP) in Qatar focused on building its public health workforce capacity.
To support key laboratory systems strengthening interventions for early disease detection, disease monitoring, and laboratory based disease surveillance for priority diseases of public health importance in Lagos, Nigeria.
To support CDC with diagnostic development and processing for the global Guinea Worm Eradication Program (GWEP). This project will provide CDC with the laboratory support needed to diagnose possible Guinea worm (GW) specimens submitted by endemic and non-endemic countries and to validate and/or develop novel Guinea worm diagnostic tests.
To leverage the WHO Global Rotavirus Surveillance Network (GRSN) by using novel technology to achieve a better understanding of the role of enteric pathogens other than rotavirus in childhood diarrhea requiring hospitalization and create the Global Pediatric Diarrheal Surveillance Network (GPDS).
To honor and recognize important work to promote safe injection practices and patient safety and produce educational materials that raise awareness and highlight the work of the One & Only Campaign.
To develop a Global Pediatric Norovirus Laboratory Surveillance Network to monitor norovirus strains and provide data critical for decision-making related to norovirus vaccination.
To support two annual two-day conferences for journalists from media outlets reaching rural, frontier and urban populations to provide training on where to access reliable health information.
To screen a subset of human and mouse monoclonal antibodies for their ability to neutralize GI.1; a time ordered panel of GII.4; and GII.3 noroviruses using a novel human intestinal enteroid cell culture system.
To ensure impact and effectiveness of rotavirus vaccines and sustain vaccine use by policy makers, physicians and parents to increase the speed of adoption of vaccine by other countries in Africa and around the world.
To engage communities through the power of arts and culture to educate, empower and mobilize individuals toward positive change. Thriving Together Atlanta serves as a model of how cross-sector partnerships can address multifaceted issues affecting communities today.
To investigate the biocompatibility, the drug release profile and length of prophylactic efficacy of a biodegradable subcutaneous implant containing antiretroviral drug(s), developed by RTI.
To help implement the CDC Foundation programs and activities supporting the Targeted Country Assistance portion of the 2022-2025 Partners’ Engagement Framework.
